Introduction {#sec1-1}
============

GAVE a rare cause of upper GI bleed has prominent associations with autoimmune disorders and liver cirrhosis. We report a case of Chronic kidney disease stage 5 with Chronic liver disease who presented with blood loss anemia and was found to have vascular ectasia involving both the antrum and duodenum. She was treated successfully with Argon Plasma coagulation.

Case Report {#sec1-2}
===========

A middle-aged woman, a known case of hypertension and stage V chronic kidney disease (CKD) since 10 years, and on maintenance hemodialysis (MHD) for 6 years, presented with complaints of blood in the stools since the past 8 months, and abdominal distention and discomfort since the past 2 months. She was diagnosed with chronic liver disease (CLD) related to hepatitis C virus (HCV) 8 months back. As a result of continuous loss of blood in the stools, the patient had developed severe anemia, for which she had received multiple blood transfusions during the past 8 months. On examination, her BP was 160/70 mmHg and PR 106/min, and she had severe pallor. An abdominal examination revealed free fluid with no organomegaly, whereas the other systems were unremarkable. Her laboratory investigations revealed severe iron-deficiency anemia with hemoglobin of 4.3 gm/dl. Her HCV genotype was one with the RNA copies of 8.5 × 10^6^ IU/ml. Ascitic fluid analysis revealed high serum-ascites albumin gradient (SAAG). Ultrasonography (USG) of her abdomen was suggestive of CLD with cirrhotic changes, with normal portal vein and bilateral contracted kidneys, without any organomegaly. The hepatic venous pressure gradient was 5 mmHg. During her hospital stay, she was given hemodialysis along with blood transfusion and intravenous (IV) iron in view of the severe iron deficiency. As she had melena, she was taken for upper gastrointestinal (GI) endoscopy and colonoscopy, where she was found to have multiple linear gastric vascular malformations in the antrum, compatible with gastric antral vascular ectasia (GAVE), with spurt oozing \[[Figure 1](#F1){ref-type="fig"}\]. There were also ectasias in the cardia and the duodenum \[[Figure 2](#F2){ref-type="fig"}\]. There were no esophageal varices. Argon plasma coagulation (APC) was done for GAVE to which she responded well \[[Figure 3](#F3){ref-type="fig"}\]. Her colonoscopy was normal. Subsequently the altered blood in stools decreased, her blood transfusion requirement decreased, and she was discharged on a conservative line of management.
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Discussion {#sec1-3}
==========

Although previously reported in the literature, GAVE or watermelon stomach was first described definitively by Jabbari *et al*.\[[@ref1]\] Although known to be associated with a number of conditions like cirrhosis, CKD, collagen vascular diseases and pernicious anemia, the exact etiopathogenesis of GAVE remains unknown.\[[@ref2]\] The most common reported association is with autoimmune disorders, whereas cirrhosis accounts for 30% of the condition in these patients.\[[@ref3]\] The incidence of GAVE in CKD is unknown, with few relevant publications in the literature.\[[@ref4]\]

Our case was interesting as incidentally the patient had both CKD and CLD, both of which are associated with GAVE. However, as the history of CKD was of 10 years, whereas HCV-related CLD was recently diagnosed, the possibility of CKD-associated GAVE was more likely. Moreover, her USG revealed a normal portal vein, with a normal size cirrhotic liver. Absence of portal hypertension ruled out the possibility of portal hypertensive gastropathy, which has an endoscopic appearance similar to that of GAVE.\[[@ref5]\] Besides the antrum, the patient also had vascular ectasias affecting the first part of the duodenum. There are reports of duodenal vascular ectasia in association with GAVE, even in patients with a normal antrum.\[[@ref6]\]

The treatment modalities for GAVE include pharmacological, surgical, and endoscopic therapies. Pharmacological treatments with documented efficacy are tranexamic acid, estrogen--progesterone therapy, especially in renal failure,\[[@ref7]\] and octreotide injections. However, these are mainly case reports or small case series. Even as surgical antrectomy provides the most definitive therapy for GAVE, it is associated with significant morbidity and mortality.

Various endoscopic treatments have been described to manage GAVE, including Neodymium: yttrium--aluminum garnet (Nd: YAG) laser, APC, and a heater probe. Of these, APC is the most frequently used endoscopic treatment, as it is easier and safer to use, with limited depth of penetration and a tendency for the ionized electric arc to deflect away from the coagulated tissue to the surrounding mucosa.\[[@ref8]\]

The number of sessions needed to eradicate GAVE depends on the pattern, extent, and number of lesions. In our case, the patient was managed effectively with APC in a single session, with a decline in gastric blood loss and requirement of blood transfusion.

To conclude, GAVE is a rare cause of persistent GI blood loss, with a known association with CKD. Presenting as transfusion-dependent anemia, it can be effectively eradicated by endoscopic therapies, especially APC, as in our case.
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